Complix to Present at Upcoming BioEquity Europe 2013: http://t.co/jzPUX0k7Bp
FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.
FlandersBio beschikt over een geüpdate databank met een overzicht van de Vlaamse bedrijven met biotechactiviteit en alle FlandersBio-leden. De databank verleent een makkelijke en vlugge toegang tot de lokale biowetenschappen-gemeenschap.
Formac Pharmaceuticals is a leading drug delivery company offering a unique mesoporous silica-based technology to enhance the oral bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs).
In 2011 Formac entered into a strategic partnership with WR Grace & Co, a leading global supplier of specialty chemicals and materials. The partnership combines the cutting-edge drug delivery expertise of Formac with the 150 years of silica design and manufacturing knowhow of Grace.
FORMAC is a pharmaceutical R&D company engaged in drug delivery and development. Our mission is to increase pharmaceutical R&D productivity and product value by enhancing the performance of (pre)clinical drug candidates and marketed drugs.
FORMAC has developed a unique oral drug delivery technology platform, including three technologies to enhance the bioavailability of poorly soluble compounds and one technology to develop tailor-made controlled release formulations.
FORMAC uses its proprietary drug delivery technologies as a starting-point for the development and commercialization of improved delivery forms of marketed drugs. In addition, FORMAC licenses its technology platform to pharmaceutical companies for formulation development of pre-clinical drug candidates and for the development of line extensions of advanced clinical drug candidates (life cycle management).
FORMAC is a privately held company established in 2007 as a spin-off project from the University of Leuven (K.U.Leuven).
FORMAC is a technology-based company applying a product-focused strategy with the objective to build over the next few years a balanced product-portfolio in one or two disease areas.
In order to fully exploit its unique technology platform, FORMAC applies a dual business approach using the proceeds generated by contract R&D activities to accelerate and expand its internal development programs, which eventually will be partnered with pharmaceutical and generic drug companies. This strategy will allow us to progressively increase value for our shareholders, employees, corporate partners and patients.
Phone: +32 16 751 370
Fax: +32 16 751 301
Foundation date: 2007